Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01061775 · ClinicalTrials.gov registry record · Phase 1

Effects of Exenatide on Hypothalamic Obesity

A Phase 1 study of Hypothalamic Obesity, sponsored by Children's Hospitals and Clinics of Minnesota.

Completed
Registry status
Phase 1
Development phase
19
Enrollment target
2
Study locations

NCT01061775 is a Phase 1 study of Hypothalamic Obesity that has completed, run by Children's Hospitals and Clinics of Minnesota. The registered enrollment target is 19 participants, below the 74-participant average among 5 other Hypothalamic Obesity trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01061775, a Phase 1 study of Hypothalamic Obesity, has completed, sponsored by Children's Hospitals and Clinics of Minnesota.

COMPLETED
Registry status
Phase 1
Development phase
19 participants
Enrollment target
2
Study locations

Study Summary

The primary aim of this study is to evaluate the effect of Exenatide on weight status (change in body mass index) of children treated for craniopharyngioma that have developed hypothalamic obesity at Children's Hospitals and Clinics of Minnesota. We hypothesize that Exenatide given to hypothalamic obese children for 6 months will reduce their body mass index significantly from baseline.

Conditions Studied

Hypothalamic Obesity

Interventions

  • DRUG Exenatide

Study Locations (2)

California

  • Children's Hospital of Orange County - Orange

Minnesota

  • Children's Hospitals & Clincis of Minnesota - Saint Paul

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2010-01
Est. Completion 2019-03-15
Phase Phase 1

Sponsor

Children's Hospitals and Clinics of Minnesota

31 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01061775

The ClinicalTrials.gov registry entry for NCT01061775 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 74-participant average among 5 other Hypothalamic Obesity trials with a reported enrollment target (74% lower). The listed sponsor is Children's Hospitals and Clinics of Minnesota, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypothalamic Obesity appearing as the primary indexed condition, and to 1 intervention - of which Exenatide is the first listed.

NCT01061775 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Minnesota.

Frequently Asked Questions

What is clinical trial NCT01061775 about?

NCT01061775 is a clinical study titled "Effects of Exenatide on Hypothalamic Obesity". The primary aim of this study is to evaluate the effect of Exenatide on weight status (change in body mass index) of children treated for craniopharyngioma that have developed hypothalamic obesity at Children's Hospitals and Clinics of Minnesota. We hypothesize that Exenatide given to hypothalamic o...

What is the current status of trial NCT01061775?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2010-01. Estimated completion is 2019-03-15.

What conditions does trial NCT01061775 study?

This clinical trial studies the following conditions: Hypothalamic Obesity.

What interventions are being tested in trial NCT01061775?

The interventions under investigation include: Exenatide (DRUG).

Who is sponsoring clinical trial NCT01061775?

This trial is sponsored by Children's Hospitals and Clinics of Minnesota, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01061775 being conducted?

This trial has 2 study locations across California, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypothalamic Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypothalamic Obesity

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.